X4 Pharmaceuticals, Inc.

DB:48Q Stock Report

Market Cap: €98.8m

X4 Pharmaceuticals Management

Management criteria checks 3/4

X4 Pharmaceuticals' CEO is Paula Ragan, appointed in Jul 2014, has a tenure of 10.17 years. total yearly compensation is $2.04M, comprised of 30.3% salary and 69.7% bonuses, including company stock and options. directly owns 0.45% of the company’s shares, worth €448.81K. The average tenure of the management team and the board of directors is 3.4 years and 5.5 years respectively.

Key information

Paula Ragan

Chief executive officer

US$2.0m

Total compensation

CEO salary percentage30.3%
CEO tenure10.2yrs
CEO ownership0.5%
Management average tenure3.4yrs
Board average tenure5.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Paula Ragan's remuneration changed compared to X4 Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

US$18m

Mar 31 2024n/an/a

-US$129m

Dec 31 2023US$2mUS$620k

-US$101m

Sep 30 2023n/an/a

-US$111m

Jun 30 2023n/an/a

-US$131m

Mar 31 2023n/an/a

-US$96m

Dec 31 2022US$4mUS$583k

-US$96m

Sep 30 2022n/an/a

-US$103m

Jun 30 2022n/an/a

-US$102m

Mar 31 2022n/an/a

-US$100m

Dec 31 2021US$2mUS$562k

-US$103m

Sep 30 2021n/an/a

-US$85m

Jun 30 2021n/an/a

-US$82m

Mar 31 2021n/an/a

-US$78m

Dec 31 2020US$3mUS$543k

-US$62m

Sep 30 2020n/an/a

-US$55m

Jun 30 2020n/an/a

-US$55m

Mar 31 2020n/an/a

-US$53m

Dec 31 2019US$2mUS$492k

-US$53m

Sep 30 2019n/an/a

-US$55m

Jun 30 2019n/an/a

-US$46m

Mar 31 2019n/an/a

-US$40m

Dec 31 2018US$921kUS$380k

-US$36m

Compensation vs Market: Paula's total compensation ($USD2.04M) is above average for companies of similar size in the German market ($USD509.52K).

Compensation vs Earnings: Paula's compensation has been consistent with company performance over the past year.

CEO

Paula Ragan (54 yo)

10.2yrs

Tenure

US$2,044,761

Compensation

Dr. Paula Ragan, Ph D., is Member of Advisory Board of Tippingpoint Biosciences, Inc. Dr. Ragan serves as an Independent Director of CAMP4 Therapeutics Corporation since May 2019. She is a Founder of X4 Ph...

Leadership Team

NamePositionTenureCompensationOwnership
Paula Ragan
CEO, President & Director10.2yrsUS$2.04m0.45%
$ 448.8k
Adam Mostafa
CFO, Treasurer & Corporate Secretary6yrsUS$1.15mno data
Christophe Arbet-Engels
Chief Medical Officer1.1yrsUS$1.64mno data
Richard Peters
Founderno datano datano data
Renato Skerlj
Founderno datano datano data
Keith Flaherty
Founder & Member of Corporate Advisory Boardno datano datano data
Mary DiBiase
Chief Operating Officer3yrsUS$1.84m0.17%
$ 169.6k
Arthur Taveras
Chief Scientific Officer3.8yrsno data0.14%
$ 137.4k
Robert Arbeit
Senior Vice President of Clinical Development and Translational Researchno datano datano data
Mark Baldry
Chief Commercial Officer1.8yrsno data0.015%
$ 14.5k

3.4yrs

Average Tenure

60yo

Average Age

Experienced Management: 48Q's management team is considered experienced (3.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Paula Ragan
CEO, President & Director10.2yrsUS$2.04m0.45%
$ 448.8k
Keith Flaherty
Founder & Member of Corporate Advisory Board8.4yrsno datano data
Michael Wyzga
Independent Chairman of the Board6.2yrsUS$199.34k0.045%
$ 45.0k
Gary Bridger
Director5.5yrsUS$147.05k0.031%
$ 30.3k
David W. McGirr
Independent Director7yrsUS$166.05k0.031%
$ 30.3k
Alison Lawton
Independent Director3.9yrsUS$154.55k0.031%
$ 30.3k
William Aliski
Independent Director5yrsUS$165.05k0.031%
$ 30.3k
Michael Vasconcelles
Member of Corporate Advisory Board8.4yrsno datano data
Robert Woods
Independent Directorless than a yearUS$91.83kno data
Murray Stewart
Director5.5yrsUS$90.08k0.087%
$ 85.9k
Francoise de Craecker
Independent Director2.9yrsUS$152.05k0.031%
$ 30.3k

5.5yrs

Average Tenure

62yo

Average Age

Experienced Board: 48Q's board of directors are considered experienced (5.5 years average tenure).